<?xml version='1.0' encoding='utf-8'?>
<document id="19558011"><sentence text="Augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Rican and Mexican children." /><sentence text="Ethnic-specific interactions between different asthma medications are not well described" /><sentence text="" /><sentence text="To determine whether the use of leukotriene modifiers is associated with the magnitude of bronchodilator responsiveness among Mexican American and Puerto Rican children with persistent asthma"><entity charOffset="32-43" id="DDI-PubMed.19558011.s4.e0" text="leukotriene" /></sentence><sentence text="" /><sentence text="A cross-sectional study of 84 Mexican American and 192 Puerto Rican children, with persistent asthma who were aged 8 to 16 years" /><sentence text=" Within each group, bronchodilator responsiveness to albuterol, objectively assessed via spirometry, was compared between participants using leukotriene modifiers and those not using leukotriene modifiers"><entity charOffset="53-62" id="DDI-PubMed.19558011.s7.e0" text="albuterol" /><entity charOffset="141-152" id="DDI-PubMed.19558011.s7.e1" text="leukotriene" /><entity charOffset="183-194" id="DDI-PubMed.19558011.s7.e2" text="leukotriene" /><pair ddi="false" e1="DDI-PubMed.19558011.s7.e0" e2="DDI-PubMed.19558011.s7.e0" /><pair ddi="false" e1="DDI-PubMed.19558011.s7.e0" e2="DDI-PubMed.19558011.s7.e1" /><pair ddi="false" e1="DDI-PubMed.19558011.s7.e0" e2="DDI-PubMed.19558011.s7.e2" /><pair ddi="false" e1="DDI-PubMed.19558011.s7.e1" e2="DDI-PubMed.19558011.s7.e1" /><pair ddi="false" e1="DDI-PubMed.19558011.s7.e1" e2="DDI-PubMed.19558011.s7.e2" /></sentence><sentence text="" /><sentence text="Leukotriene modifier use was associated with a clinically significant increase in percentage change in forced expiratory volume in 1 second of 11"><entity charOffset="0-11" id="DDI-PubMed.19558011.s9.e0" text="Leukotriene" /></sentence><sentence text="8 (P &lt; " /><sentence text="001) in Puerto Rican children, but there was no significant change in percentage change in forced expiratory volume in 1 second (-3" /><sentence text="2, P=" /><sentence text="57) in Mexican American children" /><sentence text=" This finding persisted after controlling for the use of inhaled corticosteroids"><entity charOffset="65-80" id="DDI-PubMed.19558011.s14.e0" text="corticosteroids" /></sentence><sentence text=" In addition, among the Puerto Rican children, the association between leukotriene modifier use and augmented bronchodilator responsiveness was greatest in those younger than 12 years" /><sentence text="" /><sentence text="Among children with persistent asthma, use of leukotriene modifiers is associated with augmented bronchodilator responsiveness to albuterol in Puerto Ricans, but not Mexican Americans"><entity charOffset="46-57" id="DDI-PubMed.19558011.s17.e0" text="leukotriene" /><entity charOffset="130-139" id="DDI-PubMed.19558011.s17.e1" text="albuterol" /><pair ddi="false" e1="DDI-PubMed.19558011.s17.e0" e2="DDI-PubMed.19558011.s17.e0" /><pair ddi="false" e1="DDI-PubMed.19558011.s17.e0" e2="DDI-PubMed.19558011.s17.e1" /></sentence><sentence text=" This ethnic-specific, drug-drug interaction highlights the need for the further understanding of asthma pharmacogenetics among children from different ethnic groups to improve asthma outcomes" /><sentence text="" /></document>